142 related articles for article (PubMed ID: 33042341)
21. Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.
Rodrigues MF; Truong PT; McKevitt EC; Weir LM; Knowling MA; Wai ES
Cancer Radiother; 2018 Apr; 22(2):112-119. PubMed ID: 29523388
[TBL] [Abstract][Full Text] [Related]
22. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
[TBL] [Abstract][Full Text] [Related]
23. A subset of malignant phyllodes tumors express p63 and p40: a diagnostic pitfall in breast core needle biopsies.
Cimino-Mathews A; Sharma R; Illei PB; Vang R; Argani P
Am J Surg Pathol; 2014 Dec; 38(12):1689-96. PubMed ID: 25046342
[TBL] [Abstract][Full Text] [Related]
24. Comparison of stromal CD10 expression in benign, borderline, and malignant phyllodes tumors among Egyptian female patients.
Ibrahim WS
Indian J Pathol Microbiol; 2011; 54(4):741-4. PubMed ID: 22234101
[TBL] [Abstract][Full Text] [Related]
25. Phyllodes tumor of the breast: role of CD10 in predicting metastasis.
Al-Masri M; Darwazeh G; Sawalhi S; Mughrabi A; Sughayer M; Al-Shatti M
Ann Surg Oncol; 2012 Apr; 19(4):1181-4. PubMed ID: 22006372
[TBL] [Abstract][Full Text] [Related]
26. Recurrent challenges in the evaluation of fibroepithelial lesions.
Giri D
Arch Pathol Lab Med; 2009 May; 133(5):713-21. PubMed ID: 19415945
[TBL] [Abstract][Full Text] [Related]
27. Phyllodes tumors of the breast segregate in two groups according to genetic criteria.
Laé M; Vincent-Salomon A; Savignoni A; Huon I; Fréneaux P; Sigal-Zafrani B; Aurias A; Sastre-Garau X; Couturier J
Mod Pathol; 2007 Apr; 20(4):435-44. PubMed ID: 17334353
[TBL] [Abstract][Full Text] [Related]
28. A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.
Cimino-Mathews A; Hicks JL; Sharma R; Vang R; Illei PB; De Marzo A; Emens LA; Argani P
Hum Pathol; 2013 Nov; 44(11):2494-500. PubMed ID: 23916291
[TBL] [Abstract][Full Text] [Related]
29. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
Kim GE; Kim NI; Park MH; Lee JS
Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
[TBL] [Abstract][Full Text] [Related]
30. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors.
Barth RJ
Breast Cancer Res Treat; 1999 Oct; 57(3):291-5. PubMed ID: 10617306
[TBL] [Abstract][Full Text] [Related]
31. Classic illustrations of benign and malignant phyllodes breast tumors in two patients.
Constante SA; O'Connor S; Jordan SG
Radiol Case Rep; 2023 Jan; 18(1):232-238. PubMed ID: 36340228
[TBL] [Abstract][Full Text] [Related]
32. Phyllodes tumors of the breast: natural history, diagnosis, and treatment.
Telli ML; Horst KC; Guardino AE; Dirbas FM; Carlson RW
J Natl Compr Canc Netw; 2007 Mar; 5(3):324-30. PubMed ID: 17439760
[TBL] [Abstract][Full Text] [Related]
33. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
[TBL] [Abstract][Full Text] [Related]
34. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.
Lawton TJ; Acs G; Argani P; Farshid G; Gilcrease M; Goldstein N; Koerner F; Rowe JJ; Sanders M; Shah SS; Reynolds C
Int J Surg Pathol; 2014 Dec; 22(8):695-8. PubMed ID: 25161205
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
Di Liso E; Bottosso M; Lo Mele M; Tsvetkova V; Dieci MV; Miglietta F; Falci C; Faggioni G; Tasca G; Giorgi CA; Giarratano T; Mioranza E; Michieletto S; Saibene T; Dei Tos AP; Conte P; Guarneri V
ESMO Open; 2020 Oct; 5(5):e000843. PubMed ID: 33020219
[TBL] [Abstract][Full Text] [Related]
36. Benign and borderline phyllodes tumors of the breast: Clinicopathologic analysis of 205 cases with emphasis on the surgical margin status and local recurrence rate.
Genco IS; Purohit V; Hackman K; Ferreira L; Tugertimur B; Hajiyeva S
Ann Diagn Pathol; 2021 Apr; 51():151708. PubMed ID: 33513547
[TBL] [Abstract][Full Text] [Related]
37. Breast Phyllodes Tumor: A Tumor With Unpredictable Clinical Behavior.
Tomé AI; Figueiredo J; Antunes SC; Trindade M; Travancinha D
Cureus; 2023 Apr; 15(4):e37537. PubMed ID: 37193421
[TBL] [Abstract][Full Text] [Related]
38. Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08).
Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
Breast Cancer Res Treat; 2018 Sep; 171(2):335-344. PubMed ID: 29808288
[TBL] [Abstract][Full Text] [Related]
39. Trends in the Diagnosis of Phyllodes Tumors and Fibroadenomas Before and After Release of WHO Classification Standards.
Chang J; Denham L; Dong EK; Malek K; Lum SS
Ann Surg Oncol; 2018 Oct; 25(10):3088-3095. PubMed ID: 29987607
[TBL] [Abstract][Full Text] [Related]
40. Gene Expression Profiling of Fibroepithelial Lesions of the Breast.
Li X; Vail E; Maluf H; Chaum M; Leong M; Lownik J; Che M; Giuliano A; Cao D; Dadmanesh F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
